Endothelial cell VCAM-1 regulates recruitment of lymphocytes, eosinophils, mast cells, or dendritic cells during allergic inflammation. In this report, we demonstrated that, during allergic lung responses, there was reduced zonula occludens (ZO)-1 localization in lung endothelial cell 
INTRODUCTION
Inflammatory and immune surveillance signals induce the migration of blood leukocytes across vascular endothelial cells. During allergic inflammation, VCAM-1 regulates transendothelial migration of eosinophils, lymphocytes, and mast cells from the blood into the tissue. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] VCAM-1 is localized to the luminal surface of endothelial cells and endothelial cell junctions. 11 VCAM-1 also regulates recruitment of leukocytes during inflammation in atopic dermatitis, 12 inflammatory bowel disease, 13 atherosclerosis lessions, 14 LCMV infections, 15 hematopoietic stem cell recruitment to injured liver, and melanoma metastasis to the liver. [16] [17] [18] vitro 1, 23, 24 and in vivo. 19, 20, 22, 23 In in vivo studies, nonhematopoietic gp91phox knockout mice have reduced VCAM-1-dependent leukocyte recruitment in mice during allergic inflammation 20, 22, 23 and mice with an inducible endothelial cell-specific knockout of PTP1B have reduced recruitment of leukocytes to inflammatory sites during allergic inflammation. 19 It is not known whether VCAM-1 signals alter endothelial cell junction proteins during leukocyte transendothelial migration.
Migrating leukocytes encounter paracellular endothelial cell-cell junctions. In the endothelial cell junctions, several transmembrane junction proteins bind to members of the zonula occludens (ZO) protein family. [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] Dissociation of ZO-1 binding to cell junction proteins reduces junction protein affinity. The dissociation of ZO-1 from junctions in epithelial and endothelial cells is induced by phosphorylation of ZO-1. [42] [43] [44] Recruitment of ZO-1 to cell junction molecules is regulated by angiomotin 45 and ZO-1 localizes with angiomotin in cell junctions in CHO cells. [45] [46] [47] Interestingly, asthmatic patient lung endothelial cells have increased angiomotin. 48 Lung endothelial cells also exhibit increased expression of N-Cadherin during endotoxin stimulation, 49 but it is not known whether allergic inflammation upregulates lung endothelial cell N-cadherin expression. Thus, whether induction of allergic inflammation or VCAM-1 signaling alters expression or localization of ZO-1, angiomotin, or N-cadherin in endothelial cells is not known.
Here, we demonstrate that, during VCAM-1-dependent allergic lung inflammation, 3 there is an increase in N-cadherin, an increase in angiomotin, and a decrease in ZO-1 in mouse lung endothelial cell junctions. Moreover, we demonstrate that VCAM-1 signals through ROS, PKC , and PTP1B induce serine phosphorylation of ZO-1 and loss of ZO-1 from endothelial cell junctions during VCAM-1-dependent leukocyte transendothelial migration.
METHODS

Animals
Male 6-8-week-old BALB/c mice (Harlan Industries, Indianapolis, IN) were the source of resting splenic lymphocytes. All animal procedures were reviewed and approved by the Animal Care and Use Committee at Northwestern University.
Inhibitors and Abs
Inhibitors were as follows: CinnGEL-2ME and Gö-6976 from Biomol, apocynin from Acros Organics. Inhibitors and Ab crosslinking of VCAM-1 did not affect cell viability during the time courses of these studies, consistent with our previous reports. 1, 24, 25 Abs were as follows: rat anti-mouse VCAM-1 (clone MVCAM.A), mouse antihuman VCAM-1 (clone 51-10C9), rat anti-mouse VE-cadherin (CD144, cat#550548), rat IgG (isotype antibody, clone R35-95), and FITCconjugated goat anti-rabbit Ig (cat#554020; PharMingen, BD Biosciences, San Jose, CA); zenon Alexa Fluor 568-labeled (cat#Z25106, Molecular Probes, Thermo Fisher, Grand Island, NY) rat anti-mouse CD45 (clone I3/2.3), goat anti-mouse IgG1 (cat#1070-01), and goat anti-rat IgG (cat#3050-01; Southern Biotech, Birmingham, AL); 
OVA administration in vivo
Mice (8-10 mice/group) received i.p. injections (200 l) of chicken egg ovalbumin fraction V (OVA, catalog #5503, Sigma, Milwaukee, WI) (10 g)/alum or saline/alum on days 1 and 8. 20 OVA grade V was used for sensitization because it contains low endotoxin levels, which are required for adequate OVA sensitization 50 ; in contrast, high levels of endotoxin suppress the OVA response. 50 On days 15, 18, and 20, mice received intranasal endotoxin-free OVA fraction VI (150 g; catalog #A2512; Sigma) in saline or saline alone. Then, 24 h after the last treatment, lungs were lavaged and then lungs in OCT were stored at -80 • C.
Bronchoalveolar lavage (BAL) cells were counted and cytospun for differential counts. 20 Cytospins of BAL cells were differentially stained using the Diff-Quick staining kit (Dade Behring, West Sacramento, CA) and neutrophils, eosinophils, leukocytes, and monocytes were identified and counted according to morphological criteria. Frozen lung tissue sections from these OVA-treated or saline-treated mice were used for immunolabeling of ZO-1, VCAM-1, N-cadherin, and angiomotin.
Lung tissue sections were fixed in 100% ice-cold methanol for 15 min, 
Cells
The well characterized mouse endothelial cell line mHEVa that has an activated phenotype and support leukocyte transendothelial migration on VCAM-1 has been previously described. 3, 51, 52 HEV culture medium consisted of RPMI-1640 containing 1 mM HEPES (pH 7.2, Sigma, Milwaukee, WI), 10 mM NaHCO 3 (Sigma), 2 mM glutamine (Sigma), 100 units/mL penicillin (Fisher, Grand Island, NY), 100 g/mL streptomycin (Sigma), 50 g/mL gentamicin (GIBCO Laboratories, Grand Island, NY), and 20% heat-inactivated FCS. Human microvascular endothelial cells from the lung (HMEC-Ls) passage 1-4 were from Clonetics. Spleen cells from BALB/c mice were minced and pressed through a 100 m mesh screen as previously described. 1 Spleen red blood cells were lysed by hypotonic shock and counted with a hemacytometer (cat#0267110, Fisher Scientific, Grand Island, NY). 51 
Immunoprecipitation
Western blotting
Cell lysates or immunoprecipitates in SDS sample buffer were analyzed by SDS-PAGE (7.5%) and transferred to PVDF membranes according to manufacturer's instructions (300 mA for 3 h; Bio-Rad, Des Plaines, IL). Membranes were blocked in 5% nonfat dried milk or in 5% BSA 
Transient transfection with dominant negative PKC
Transient transfection with dominant negative (DN) PKC was performed and did not affect cell viability as previously described. 24, 25 Briefly, cells grown on slides were transfected with 1 g of DN PKC or the vector pCMV per well with 2 L/well LipofectAMINE 2000 Reagent (Invitrogen, Carlsbad, CA) for 3.5 h and then medium replaced.
Lymphocyte migration assay
A parallel plate flow chamber was used to examine migration under conditions of laminar flow at 2 dynes/cm 2 for 15 min as we described previously. 24 Briefly, spleen cells were used as a source of cells contiguous with the blood stream that could then migrate across endothelial cells. Spleen cell migration across the mHEV cell lines is stimulated by mHEV cell constitutive production of the chemokine MCP-1 54 and is dependent on adhesion to VCAM-1. 1 We have previously reported that, after migration across the mHEV cells, the spleen cells are 65-70% B cells, 12-15% CD4 + cells, and 5-8% CD8 + cells. 27 After 15 min at 2 dynes/cm 2 
Localization of ZO-1
Endothelial cells grown to confluence on glass slides were nontreated or pretreated with 2.3 nM Gö-6976 for 30 min and washed 5 times.
The monolayers were subjected to 2 dynes/cm 2 
Over expression of ZO-1-GFP
Statistics
Data were analyzed by a one way ANOVA followed by Tukey's multiple comparisons test (SPSS, Jandel Scientific, San Ramon, CA). (Figs. 1A-C and F) , indicative of either a change in localization of ZO-1 or a change in total ZO-1; this is addressed in the next figures. In the bronchoalveolar lavage, numbers of eosinophils, lymphocytes, monocytes and neutrophils were increased (Fig. 1E ). In the lung tissue sections (Figs. 1A-D) , the increase in blue nuclei in OVAchallenged lungs is consistent with the increase in inflammatory cells.
RESULTS
OVA challenge increases allergic inflammation, reduces endothelial ZO-1 and increases endothelial VCAM-1, angiomotin, and N-cadherin in the lung
VCAM-1 signals induce serine phosphorylation of ZO-1 in HMEC-L cells
To further examine ZO-1 expression, we determined whether (Fig. 2) . Stimulation of VCAM-1 induced serine phosphorylation (Figs. 2A-C and E) but not tyrosine phosphorylation (Fig. 2D) of ZO-1 at 15 min, the optimal time point for ZO-1 phosphorylation ( Fig. 2A and Supplementary Fig. 1A ). This is consistent with optimal VCAM-1 stimulation of PKC activation at 10 min, VCAM-1 stimulation of PTP1B activation at 15 min, and leukocyte transendothelial migration across monolayers of endothelial cells at 15 min. 24, 25 It was determined whether inhibition of VCAM-1 signals through NOX2, PKC , and PTP1B blocked VCAM-1-stimulated serine phosphorylation of ZO-1. HMEC-L cells were nontreated or treated with DN PKC and then VCAM-1 expression was induced by TNF-24,25 ;
as we have reported, 24, 25 transfection with DN PKC increases total PKC and does not alter VCAM-1 expression. To inhibit PTP1B or NADPH oxidase, TNF--treated HMEC-L cells were preincubated for 30 min with the PTP1B specific inhibitor CinnGEL (10 M), 56 the NADPH oxidase inhibitor apocynin (4 mM) or the vehicle control DMSO (0.1%) as we previously described. 1, 24, 25 Apocynin is an inhibitor of NADPH oxidase and xanthine oxidase but we have reported that VCAM-1 does not activate xanthine oxidase during leukocyte transendothelial migration. 1 The transfections and inhibitors did not affect cell viability in these studies, consistent with our previous reports. 1, 24, 25 Supplementary Fig. 1A ). ZO-1 was immunoprecipitated (i.p.) and examined by western blot with anti-phosphoserine, anti-phosphotyrosine, or anti-ZO-1. The lines in the blots indicate where spaces between lanes were removed; the original micrograph of the blot is in Supplementary Fig. 1B . All lanes were from the same blot. Data are from 3 experiments and presented as mean ± SEM. *P < 0.05 compared to nontreated or DMSO controls H 2 O 2 did stimulate HMEC-L cell ZO-1 serine phosphorylation at 15 min (Figs. 2A and B) .
VCAM-1 signals induce serine phosphorylation of ZO-1 in constitutively activated endothelial cell lines
The endothelial cell line mHEV was used in these studies because they are constitutively activate with VCAM-1 expression and provide a system to examine the functional outcome of VCAM-1 signaling during leukocyte transendothelial migration. 3, [23] [24] [25] Before examining migration, we first examined regulation of ZO-1 by VCAM-1 signals in these cells. We have reported that VCAM-1 stimulation of NOX2, PKC , and PTP1B in these cells 1, 51, 57 occurs with the same magnitude and time course as TNF--activated primary cultures of HMEC-L cells. In Fig. 3A and Supplementary Fig. 2A , stimulation of VCAM-1 with anti-VCAM-1 and a secondary Ab induced serine phosphorylation of ZO-1 at 15 min, the same time course as for HMEC-L cells (Fig. 2) . This ZO-1 phosphorylation was blocked by transfection with DN PKC or treatment with the PTP1B inhibitor CinnGel but not the vector control ( Fig. 3A and Supplementary Fig. 2A ). Anti-VCAM-1 stimulation did not increase the mHEV cell monolayer permeability ( (Fig. 4) . Importantly, there was no change in total ZO-1 as determined by western blot (Fig. 3B) , indicating a change in localization of ZO-1 in the cells rather than loss of ZO-1 in the cells. Gö-6976), or PTP1B (10 M CinnGEL-2ME) and then washed as we previously described. 1, 24, 25 The cells were placed into a parallel plate flow chamber and lymphocytes were added for 15 min under laminar flow at 2 dynes/cm 2 because this is the flow rate in postcapillary venules in vivo where leukocytes migrate into inflammatory sites. 24, 25 After 15 min, the cells were fixed and immunolabeled for ZO-1 and lymphocyte CD45 and then examined by confocal microscopy. The diagram in Fig. 6B indicates the location of the 3D imaging at the apical surface of the endothelial cells. In the paths where the bound lymphocytes had rolled (Fig. 6A column a, dashed boxes in the XY on-face view of the 3D image, and Fig. 6C , arrow in diagram of area analyzed), there was a significant loss of ZO-1 from untreated or DMSO solvent-treated endothelial cells (Fig. 6D) . The loss of ZO-1 is in the direction of leukocyte rolling as indicated with an arrow (Fig. 6A lower left micrograph). In the representative Z-slice vertically through the cells in Fig. 6A (Fig. 6A ).
Overexpression of ZO-1 increases ZO-1 in cell junctions and blocks lymphocyte migration
Inhibition of VCAM-1 signals blocked ZO-1 phosphorylation and ZO-1 dissociation from cell junctions (Figs. 2, 3 , 5, and 6) and inhibition of VCAM-1 signals blocks VCAM-1-dependent leukocyte transendothelial migration (Fig. 6A) , 1, 24, 25 (Fig. 7A) , flow cytometry for EGFP (Fig. 7B) , and fluorescence microscopy (Fig. 7C) . ZO-1 overexpression did not alter VCAM-1 expression (Fig. 7B) . The overexpression of ZO-1 significantly blocked VCAM-1-dependent lymphocyte transendothelial migration (Fig. 7D) . The vector did not affect VCAM-1-dependent migration (Fig. 7D ).
DISCUSSION
We demonstrated that lungs with allergic inflammation had increased These studies are the first to report that with allergic inflammation, there is increased N-cadherin and angiomotin and decreased ZO-1.
ZO-1 was not contiguous in the endothelial cell junctions, which is consistent with previous reports that ZO-1 is not contiguous in junctions of endothelial cells. 59, 60 An increase in expression of N-cadherin in lung endothelial cells has also been reported to increase with neutophilic inflammation induced by administration of endotoxin, 61, 62 but the mechanism was not defined. The increase in angiomotin in mouse lungs with allergic inflammation is consistent with studies in humans which demonstrated that angiomotin is expressed by lung endothelial cells in patients with asthma. 48 Moreover, angiomotin has been reported to localize with ZO-1, recruits ZO-1 to junctions in CHO cells and can be localized with cadherins in cell junctions. [45] [46] [47] Whether angiomotin mediates recovery of de-phosporylated ZO-1 back to junctions after leukocyte transendothelial migration will be addressed in future studies.
ZO-1 associates with multiple junction proteins in adherent cells [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] 45 and is regulated by ZO-1 phosphorylation. 31, 38, 63 In rabbit nasal epithelium, PKC-dependent serine phosphorylation of ZO-1 is induced by poly-L-arginine. 42 In okadaic acid-treated epithelial cells, serine or threonine phosphorylation but not tyrosine phosphorylation of ZO-1 is important for the release of ZO-1 from cell junctions. 64, 65 We demonstrated here that VCAM-1 signaling stimulated serine phosphorylation but not tyrosine phospho- There are differences in ZO-1 regulation by cell type and stimulant. In addition to serine phosphorylation of ZO-1, ZO-1 can be tyrosine phosphorylated in epithelial cells. Tyrosine phosphorylation of ZO-1 correlates with a decrease in transmembrane electrical resistance (TER) in hepatocyte growth factor-stimulated epithelial cells, 66 correlates with a decrease in TER in oxidatively stressed Caco-2 cells, 67 and correlates with increased permeability after intraocular injection of VEGF. 44 Conversely, after ZO-1 associates with the epidermal growth factor receptor, there is an increase in ZO-1 tyrosine phosphorylation that induces organization of junctions in A431 cells and primary colorectal cancer cells. 68, 69 We have shown that VCAM-1 signaling increases serine phosphorylation of PTP1B but does not alter tyrosine phosphorylation of ZO-1. and that MMP activity is not necessary for the regulation of ZO-1 phosphorylation. We also report here that these signals through 
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